Biopsy Forceps Market Size, Share & Industry Analysis, By Product Type (Flexible Biopsy Forceps and Rigid Biopsy Forceps), By Usability (Disposable and Reusable), By Application (Gastrointestinal Endoscopy, Bronchoscopy, Urology, Gynecology, Laparoscopy, ENT, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, Diagnostic/Endoscopy Centers, and Others), and Regional Forecast, 2026-2034

The global biopsy forceps market size was valued at USD 411.4 million in 2025. The market is projected to grow from USD 437.5 million in 2026 to USD 683.2 million by 2034, exhibiting a CAGR of 5.7% during the forecast period.

Biopsy forceps are handheld or endoscopy-compatible instruments used to grasp and remove small tissue samples from inside the body for pathological examination. These devices are particularly used in gastroenterology and pulmonology, where they help physicians confirm inflammatory disease, dysplasia, infection, and malignancy. The market is growing as global volumes for digestive disease and cancer screening are increasing, driving the adoption of biopsy forceps.

Furthermore, Olympus Corporation, Boston Scientific Corporation, and Cook held the highest market share in 2025 due to their broad portfolios and strong global footprints.

BIOPSY FORCEPS MARKET TRENDS

Integration of Forceps Demand with Smarter Endoscopy Ecosystems to Emerge as a Key Trend

Currently, biopsy forceps demand is increasingly tied to broader endoscopy ecosystem upgrades rather than standalone accessory replacement. As a result, key players are launching comprehensive procedural products that combine improved visualization, AI-assisted lesion detection, ergonomics, data integration, and compatible therapeutic or tissue-acquisition tools. These platforms increase endoscopists' ability to identify and sample more suspicious tissue.

• For instance, in October 2023, Olympus Corporation launched the next-generation EVIS X1 endoscopy system at the American College of Gastroenterology annual meeting in Vancouver, featuring advanced imaging technologies such as TXI, RDI, and NBI.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising GI Diagnostic Volumes and Cancer Detection Needs to Fuel Market Expansion

Over the past few years, there has been a significant surge in screening and surveillance programs for colorectal cancer, upper GI lesions, inflammatory bowel disease, Barrett’s esophagus, and suspicious polyps. All these screenings significantly depend on reliable biopsy collection. Moreover, as endoscopy systems become more advanced, physicians are identifying more lesions that require sampling, which is expected to directly increase forceps demand, thereby driving the global biopsy forceps market growth during the forecast period.

• For instance, in August 2025, the American Cancer Society National Colorectal Cancer Roundtable stated that around 15.0 million colonoscopies are performed in the U.S. each year.

MARKET RESTRAINTS

Pricing Pressure to Restrict Market Growth

One of the main restraints is cost pressure at the procedural level. Hospitals and ambulatory centers want better infection control and workflow efficiency, but they also remain highly sensitive to per-case consumable costs.  Moreover, some domestic players offer disposable products at competitive prices. This creates uneven adoption across regions and facilities, which is expected to hinder the market expansion over the forecast period.

MARKET OPPORTUNITIES

Single-Use Adoption and Advanced Tissue Acquisition to Offer Lucrative Opportunities

In recent years, endoscopy units have been under pressure to reduce infection risk, improve workflow predictability, and maintain sample quality, all of which favor the use of disposable accessories. At the same time, clinicians want better yield from smaller or harder-to-reach lesions, opening room for differentiated forceps, fine-needle biopsy devices, and precision sampling tools. This is expected to offer significant opportunities for key players to increase investment in single-use biopsy forceps.

MARKET CHALLENGES

Shortage of Skilled Endoscopy Professionals to Challenge Market Expansion

In many regions, especially emerging markets, there has been a shortage of trained endoscopists, technicians, and supporting healthcare staff required to perform diagnostic and interventional procedures, which is expected to restrict procedural volumes despite growing demand. Furthermore, in developed regions, increasing screening demand is outpacing workforce growth, leading to longer wait times and reduced procedure throughput, which is also anticipated to challenge the market expansion.

• For instance, in December 2022, the Association of American Medical Colleges (AAMC) reported an overall shortage of 37,800 to 124,000 physicians, including endoscopists, by 2034.

Segmentation Analysis

By Product Type

High Usage in GI Procedures Fuelled Flexible Biopsy Forceps Segment Growth

Based on product type, the market is segmented into flexible biopsy forceps and rigid biopsy.

To know how our report can help streamline your business, Speak to Analyst

The flexible biopsy forceps segment accounted for the largest global biopsy forceps market share in 2025. Flexible endoscopes are the standard platform for upper GI, lower GI, biliary, and pulmonary visualization, so forceps designed to pass through flexible working channels experience the highest procedure volume, which is expected to contribute to the segment’s growth.

Additionally, the rigid biopsy forceps segment is projected to grow at a 4.1% CAGR during the forecast period.

By Usability

Key Advantages of Disposable Biopsy Forceps Boosted Segment’s Growth

By usability, the market is segmented into disposable and reusable.

The disposable segment accounted for the largest market share in 2025. These devices eliminate reprocessing steps, reduce concerns about cross-contamination, and offer consistent performance from case to case, which is expected to increase their adoption and augment the segment’s growth. Moreover, the segment is estimated to hold a 69.9% share in 2026.

Additionally, the reusable segment is anticipated to grow at a 3.8% CAGR over the forecast period.

By Application

Increasing Incidence of Colorectal Cancer Boosted Gastrointestinal Endoscopy Segment’s Growth

By application, the market is classified into gastrointestinal endoscopy, bronchoscopy, urology, gynecology, laparoscopy, ENT, and others.

The gastrointestinal endoscopy segment accounted for the largest market share in 2025. The growth is attributed to the increasing incidence of colorectal cancer, which in particular sustains a continuous need for tissue sampling, driving the demand for biopsy forceps. This is anticipated to drive the segment’s growth in the forthcoming years. Moreover, the segment is projected to hold a 56.1% share in 2026.

• For instance, in April 2026, McGill University stated that in the U.S., with a population of about 340.0 million, there are over 100,000 new colon cancer cases and around 50,000 new rectal cancer cases annually.

Additionally, the bronchoscopy segment is expected to grow at a 5.5% CAGR during the forecast period.

By End-user

Increasing Diagnostic and Interventional Endoscopic Procedures in Hospitals & ASCs Propelled Segment’s Growth

On the basis of end-user, the market is segmented into hospitals & ASCs, specialty clinics, diagnostic/endoscopy centers, and others.

In 2025, hospitals & ASCs dominated the market by end-users. These settings perform the largest number of diagnostic and interventional endoscopic procedures, have established endoscopy suites, and maintain the pathology, anesthesia, and emergency support needed for biopsy-based care. As a result, the adoption of biopsy forceps is higher in these settings, which is anticipated to drive the segment’s growth. Furthermore, the segment is set to hold 55.5% share in 2026.

In addition, the diagnostic/endoscopy centers segment is projected to grow at a CAGR of 6.8% during the forecast period.

Biopsy Forceps Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest share of revenues in 2024, valued at USD 181.0 million, and also led in 2025 with a valuation of USD 193.1 million in 2025. The adoption of biopsy forceps is supported by high-endoscopy procedure volumes, strong hospital and ASC infrastructure, and the rapid adoption of advanced GI imaging systems, which are expected to fuel market expansion.

• For instance, according to the data from the Centers for Medicare & Medicaid Services (CMS) in March 2025, there were more than 6,500 Medicare-certified ASCs in the U.S.

U.S. Biopsy Forceps Market

In 2026, the U.S. is anticipated to reach USD 183.9 million, accounting for approximately 42.0% of the global market.

Europe

Europe is projected to record a 5.4% growth rate during the forecast period, the second-highest globally, reaching USD 96.2 million by 2026. The region benefits from well-developed public healthcare systems and consistent use of diagnostic endoscopy, especially in Western Europe, which is projected to drive increased use of biopsy forceps.

U.K. Biopsy Forceps Market

The U.K. market is projected to reach USD 11.6 million by 2026, representing approximately 2.7% of global revenues.

Germany Biopsy Forceps Market

Germany's market is expected to reach USD 23.2 million by 2026, accounting for approximately 5.3% of global revenue.

Asia Pacific

By 2026, the Asia Pacific’s market is projected to reach approximately USD 90.7 million, making it the third-largest market globally. The growth is attributed to the region’s large patient pool, rising cancer burden, improving hospital infrastructure, and expanding access to endoscopic diagnosis in China, Japan, India, and South Korea.

Japan Biopsy Forceps Market

Japan is projected to generate approximately USD 16.6 million in revenue by 2026, representing nearly 3.8% of the global market.

China Biopsy Forceps Market

China’s market is anticipated to reach around USD 47.6 million by 2026, accounting for nearly 10.9% of global revenues.

India Biopsy Forceps Market

India’s market is expected to reach approximately USD 6.4 million by 2026, accounting for around 1.5% of global market revenue.

Latin America and Middle East & Africa

Both Latin America and the Middle East & Africa are anticipated to witness moderate growth, with the Latin America market estimated to reach approximately USD 28.3 million by 2026. The growth is supported by the gradual expansion of private hospitals, diagnostic centers, and specialty care infrastructure, especially in urban areas.

GCC Biopsy Forceps Market

By 2026, the GCC market is estimated to reach approximately USD 7.2 million, representing around 1.6% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Broad Product Offerings Combined with Robust Distribution Networks Will Strengthen Market Position of Leading Companies

In 2025, Olympus Corporation, Boston Scientific Corporation, and Cook held the largest global market share. This share is attributed to their breadth of portfolio, compatibility with installed endoscope systems, product reliability, and strong distribution reach.

Moreover, other key players are expanding their global footprint through acquisitions, partnerships, and the launch of new manufacturing facilities. Moreover, they are also focused on new product innovation and cost-effective products to increase their market share.

LIST OF KEY BIOPSY FORCEPS COMPANIES PROFILED IN REPORT

• Olympus Corporation (Japan)
• Boston Scientific Corporation (U.S.)
• Cook (U.S.)
• CONMED Corporation (U.S.)
• STERIS (U.S.)
• Medtronic (Ireland)
• Micro-Tech (Nanjing) Co., Ltd. (China)
• KARL STORZ SE & Co. KG (Germany)
• Richard Wolf GmbH (Germany)
• ENDO-FLEX GmbH (Germany)

KEY INDUSTRY DEVELOPMENTS

• December 2024: PENTAX Medical received US FDA 510(k) clearance for new slim models of its i20c Video Endoscope Series, including the Video Colonoscope EC34-i20cL, Video Upper GI Scope EG27-i20c, and Right/Left Wheel Extender OE-B17. These advanced endoscopes feature superior imaging, enhanced maneuverability with adjustable stiffness, and ergonomic ErgoFeel controls, enabling precise passage of biopsy forceps.
• August 2024: EIZO Inc. launched the RadiForce RX670, a 30-inch 6MP radiology/teleradiology monitor with USB-C docking and comfort light.
• June 2024: Medtronic announced a distribution agreement with Dragonfly Endoscopy for pancreaticobiliary endoscopy technology designed to enable larger biopsy samples.
• May 2024: FUJIFILM Healthcare Americas announced the commercialization of CAD EYE and SCALE EYE, both integrated into the ELUXEO endoscopy platform and showcased at DDW 2024. These technologies enhance lesion visualization and sizing during colonoscopy, supporting precise navigation of biopsy forceps.
• November 2023: Olympus Corporation announced the market launch of the EVIS X1 endoscopy system in Japan, featuring advanced imaging technologies such as Texture and Shadow (TXI/TXI-CI) and Red Dichromatic Imaging (RDI) for superior GI lesion detection.
• September 2023: Limaca Medical received FDA 510(k) clearance for its Precision GI Endoscopic Ultrasound (EUS) Biopsy Device, following Breakthrough Device Designation, to enable faster, less traumatic biopsies for pancreatic and GI cancers.
• September 2023: Ambu announced FDA 510(k) clearance for its first-generation single-use colonoscope, aScope Colon, designed for sterile, efficient GI procedures that eliminate cross-contamination risks. The device features a 3.8 mm working channel compatible with standard biopsy forceps, enabling precise tissue sampling during colonoscopy for polyp detection and histological analysis.

REPORT COVERAGE

The biopsy forceps market report delivers an in-depth analysis of all market segments, highlighting key growth drivers, emerging trends, opportunities, restraints, and challenges shaping the industry. It also provides detailed insights into technological advancements, procedure volumes, significant industry developments, market share analysis, and comprehensive profiles of leading companies.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation